XML 28 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Equity
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Equity

NOTE 10. Equity

Shares Rollforward

The following tables present the changes in the number of shares of common stock issued and repurchased (in thousands):

 

 

 

Shares of Common Stock Issued

 

 

 

Shares of Treasury Stock

 

Balance, December 31, 2023

 

 

82,404

 

 

 

 

(18,150

)

Issuance of shares

 

 

2

 

 

 

 

 

Vesting of restricted share grants

 

 

382

 

 

 

 

 

Exercise of options

 

 

378

 

 

 

 

 

Shares withheld related to net settlement of equity awards

 

 

 

 

 

 

(345

)

Balance, March 31, 2024

 

 

83,166

 

 

 

 

(18,495

)

Issuance of shares

 

 

1

 

 

 

 

 

Vesting of restricted share grants

 

 

18

 

 

 

 

 

Exercise of options

 

 

269

 

 

 

 

 

Shares withheld related to net settlement of equity awards

 

 

 

 

 

 

(151

)

Balance, June 30, 2024

 

 

83,454

 

 

 

 

(18,646

)

Issuance of shares

 

 

2

 

 

 

 

 

Vesting of restricted share grants

 

 

49

 

 

 

 

 

Exercise of options

 

 

175

 

 

 

 

 

Shares withheld related to net settlement of equity awards

 

 

 

 

 

 

(110

)

Balance, September 30, 2024

 

 

83,680

 

 

 

 

(18,756

)

 

 

 

 

Shares of Common Stock Issued

 

 

 

Shares of Treasury Stock

 

Balance, December 31, 2022

 

 

80,528

 

 

 

 

(13,203

)

Issuance of shares

 

 

3

 

 

 

 

 

Repurchase of shares

 

 

 

 

 

 

(1,032

)

Vesting of restricted share grants

 

 

680

 

 

 

 

 

Exercise of options

 

 

295

 

 

 

 

 

Shares withheld related to net settlement of equity awards

 

 

 

 

 

 

(390

)

Balance, March 31, 2023

 

 

81,506

 

 

 

 

(14,625

)

Issuance of shares

 

 

2

 

 

 

 

 

Repurchase of shares

 

 

 

 

 

 

(1,380

)

Vesting of restricted share grants

 

 

27

 

 

 

 

 

Exercise of options

 

 

191

 

 

 

 

 

Shares withheld related to net settlement of equity awards

 

 

 

 

 

 

(102

)

Balance, June 30, 2023

 

 

81,726

 

 

 

 

(16,107

)

Issuance of shares

 

 

2

 

 

 

 

 

Vesting of restricted share grants

 

 

66

 

 

 

 

 

Exercise of options

 

 

430

 

 

 

 

 

Shares withheld related to net settlement of equity awards

 

 

 

 

 

 

(206

)

Balance, September 30, 2023

 

 

82,224

 

 

 

 

(16,313

)

Shares Repurchased and Withheld

Share Repurchase Programs

In December 2023, the Company’s Board of Directors approved a new share repurchase program (the “2024 Share Repurchase Program”) authorizing the repurchase of up to $100.0 million of the Company’s Common Stock through December 31, 2025. Under the 2024 Share Repurchase Program, which took effect in December 2023, the Company may purchase its shares from time to time in privately negotiated transactions, through block trades, pursuant to open market purchases, or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the SEC. The amount and timing of purchases under the 2024 Share Repurchase Program will depend on a number of factors including the price and availability of the Company’s shares, trading volume, capital availability, Company performance and general economic and market conditions. The 2024 Share Repurchase Program can be suspended or discontinued at any time.

No shares were repurchased by the Company during the three and nine months ended September 30, 2024 and the three months ended September 30, 2023. During the nine months ended September 30, 2023, the Company repurchased 2.4 million shares of Common Stock at a total cost of $77.3 million, which included $0.5 million of excise taxes payable on shares repurchased, for an average price of $32.05 per share.

As of September 30, 2024, $95.2 million was available for future repurchases under the 2024 Share Repurchase Program, and a cumulative total of 11.3 million shares of Common Stock had been repurchased under programs authorized by the Company’s Board of Directors at a total cost of $295.8 million for an average price of $26.26 per share.

Shares Withheld for net settlement of employee equity awards

During the three months ended September 30, 2024, the Company net settled 0.1 million shares of Common Stock for $5.8 million to satisfy $4.2 million in employee tax obligations and $1.6 million in employee stock option exercise prices. During the same period in 2023, 0.2 million shares were net settled for $6.9 million to satisfy $5.0 million of employee tax obligations and $1.9 million of employee stock option exercise prices.

During the nine months ended September 30, 2024, the Company net settled 0.6 million shares of Common Stock for $26.4 million to satisfy $19.7 million in employee tax obligations and $6.7 million in employee stock option exercise prices. During the same period in 2023, 0.7 million shares were net settled for $21.7 million to satisfy $16.7 million of employee tax obligations and $5.0 million of employee stock option exercise prices.

Dividend Payments

Dividends paid or payable for the nine months ended September 30, 2024 totaled $73.1 million and included quarterly dividends of $72.2 million and $0.9 million in cash bonuses and distributions related to dividends previously declared upon vesting of restricted stock. During the same period in 2023, dividends paid or payable totaled $64.8 million and included

quarterly dividends of $63.6 million and $1.2 million in cash bonuses and distributions related to dividends previously declared upon vesting of restricted stock.

As of September 30, 2024 and December 31, 2023, the amount of cash bonuses and distributions related to dividends previously declared on unvested and outstanding restricted share awards and stock options totaled $1.2 million, which was not recorded as a liability as of the balance sheet date. A liability will be recorded for these cash bonuses and dividends when the restricted shares and options vest.